Feasibility of pharmacokinetic parametric PET images in scaled subprofile modelling using principal component analysis

D. bora E. Peretti, Remco J. Renken, Fransje E. Reesink, Bauke M. de Jong, Peter P. de Deyn, Rudi A. J. O. Dierckx, Janine Doorduin, Ronald Boellaard, David Vállez García

Research output: Contribution to journalArticleAcademicpeer-review

4 Citations (Scopus)


Scaled subprofile model using principal component analysis (SSM/PCA) is a multivariate analysis technique used, mainly in [18F]-2-fluoro-2-deoxy-D-glucose (FDG) PET studies, for the generation of disease-specific metabolic patterns (DP) that may aid with the classification of subjects with neurological disorders, like Alzheimer's disease (AD). The aim of this study was to explore the feasibility of using quantitative parametric images for this type of analysis, with dynamic [11C]-labelled Pittsburgh Compound B (PIB) PET data as an example. Therefore, 15 AD patients and 15 healthy control subjects were included in an SSM/PCA analysis to generate four AD-DPs using relative cerebral blood flow (R1), binding potential (BPND) and SUVR images derived from dynamic PIB and static FDG-PET studies. Furthermore, 49 new subjects with a variety of neurodegenerative cognitive disorders were tested against these DPs. The AD-DP was characterized by a reduction in the frontal, parietal, and temporal lobes voxel values for R1 and SUVR-FDG DPs; and by a general increase of values in cortical areas for BPND and SUVR-PIB DPs. In conclusion, the results suggest that the combination of parametric images derived from a single dynamic scan might be a good alternative for subject classification instead of using 2 independent PET studies.
Original languageEnglish
Article number102625
JournalNeuroImage: Clinical
Publication statusPublished - 1 Jan 2021


  • Alzheimer's disease
  • Disease pattern
  • Pharmacokinetic modelling
  • Pittsburgh compound B

Cite this